Increased Proportions of Bifidobacterium and the Lactobacillus Group and Loss of Butyrate-Producing Bacteria in Inflammatory Bowel Disease
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Dysbiosis in the intestinal microbiota of persons with inflammatory bowel disease (IBD) has been described, but there are still varied reports on changes in the abundance of Bifidobacterium and Lactobacillus organisms in patients with IBD. The aim of this investigation was to compare the compositions of mucosa-associated and fecal bacteria in patients with IBD and in healthy controls (HCs). Fecal and biopsy samples from 21 HCs, 21 and 15 Crohn's disease (CD) patients, and 34 and 29 ulcerative colitis (UC) patients, respectively, were analyzed by quantitative real-time PCR targeting the 16S rRNA gene. The bacterial numbers were transformed into relative percentages for statistical analysis. The proportions of bacteria were uniformly distributed along the colon regardless of the disease state. Bifidobacterium was significantly increased in the biopsy specimens of active UC patients compared to those in the HCs (4.6% versus 2.1%, P = 0.001), and the proportion of Bifidobacterium was significantly higher in the biopsy specimens than in the fecal samples in active CD patients (2.7% versus 2.0%, P = 0.012). The Lactobacillus group was significantly increased in the biopsy specimens of active CD patients compared to those in the HCs (3.4% versus 2.3%, P = 0.036). Compared to the HCs, Faecalibacterium prausnitzii was sharply decreased in both the fecal and biopsy specimens of the active CD patients (0.3% versus 14.0%, P < 0.0001 for fecal samples; 0.8% versus 11.4%, P < 0.0001 for biopsy specimens) and the active UC patients (4.3% versus 14.0%, P = 0.001 for fecal samples; 2.8% versus 11.4%, P < 0.0001 for biopsy specimens). In conclusion, Bifidobacterium and the Lactobacillus group were increased in active IBD patients and should be used more cautiously as probiotics during the active phase of IBD. Butyrate-producing bacteria might be important to gut homeostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with inflammatory bowel disease (IBD) have been associated with reduced bacterial diversity and a decline in butyrate-producing bacteria such as Faecalibacterium prausnitzii, indicating the importance of gut dysbiosis in IBD [138, 139].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [139]
In the citing paper
“mucosa-associated microbes preferentially regulate host homeostasis, as is evident in the induction of T-cell immune responses, as well as maintaining serotonin biosynthesis from dietary tryptophan in the mucosa.28, 29, 30, 31, 32, 33”
From Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder (2017) · cites this paper as [28]
Citations
Cites
The gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029 · cited 1×
“In our study, we found that the proportions of detected mucosa-associated bacteria in healthy gastrointestinal tracts were uniformly distributed along the colon, which was in accordance with the findings from a previous study (23, 24).”
ResultFrank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 2×
“leptum group was strikingly low in mucosa-associated microbiotas (40, 41).”
BackgroundSokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413 · cited 1×
“One study suggested that Faecalibacterium prausnitzii prevents 2,4,6-trinitrobenzenesulfonic acid (TNBS)induced colitis (16).”
BackgroundDevelopment of a Crohn's Disease Activity Index
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80163-1 · Cited by 3,152
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
Microbial Influences in Inflammatory Bowel Diseases
Sartor, R. B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.059 · Cited by 1,927
Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis
Sartor, R. B. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0528 · Cited by 1,757
Microbes in Gastrointestinal Health and Disease
Neish, A. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.080 · Cited by 1,386
Mucosal flora in inflammatory bowel disease
Swidsinski, A., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening–Baucke, V., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.30294 · Cited by 1,346
Kruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285
Cited by
Items 401–500 of 510
Lin, L., Li, S., Liu, Q., Zhang, X., Xiong, Y., Zhao, S., Cao, L., Gong, J., Liu, Y., & Wu, R. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1492783 · Cited by 4
Ju, H. J., Song, W., Shin, J. H., Lee, J. H., Bae, J. M., Lee, Y. B., & Lee, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072939 · Cited by 5
“Comprehensive meta-analysis by Wang et al. synthesized data from multiple studies, confirming consistent patterns of reduced microbial diversity and altered metabolic pathways across different populations with vitiligo [22].”
Pathogenesis of Inflammatory Bowel Disease
Dolu, S. (2025) · Journal of Enterocolitis · doi:10.14744/jenterocolitis.2025.15570 · Cited by 5
Etiopathogenesis of Inflammatory Bowel Diseases
Mrowicki, J., Mrowicka, M., Dziki, A. J., Dziki, Ł. A., & Majsterek, I. (2018) · Biomarkers Journal · doi:10.21767/2472-1646.100046 · Cited by 3
Nugraha, D., Putri, N. A. S., Visuddho, V., & Wungu, C. D. K. (2021) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2021.01038 · Cited by 3
Premkumar, K., Ramadass, B., & Ramakrishna, B. S. (2022) · Gastroenterology Hepatology and Endoscopy Practice · doi:10.4103/ghep.ghep_18_22 · Cited by 4
Rodriguez, D. M., Hintze, K. J., Rompato, G., Stewart, E. C., Barton, A. H., Mortensen, E., Green, P. A., Wettere, A. J. V., Thomas, A. J., & Benninghoff, A. D. (2023) · Nutrients · doi:10.3390/nu15061338 · Cited by 3
Lü, F., MacPherson, C. W., Tremblay, J., Iskandar, M. M., & Kubow, S. J. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1130841 · Cited by 5
“An increased abundance of Bifidobacterium has been reported in patients with irritable bowel disease (76).”
BackgroundChen, X., Song, W., Xiong, P., Cheng, D., Wei, W., Zhou, Q., Xu, C., Song, Q., Ji, H., Hu, Y., et al. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1456181 · Cited by 4
Mikrobiom und Ernährung: Therapie der Zukunft für chronisch-entzündliche Darmerkrankungen?
Schreiber, S., Nikolaus, S., & Rosenstiel, P. C. (2014) · Der Internist · doi:10.1007/s00108-013-3443-0 · Cited by 10
Hankel, J., Mößeler, A., Hartung, C. B., Rath, S., Schulten, L., Visscher, C., Kamphues, J., & Vital, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911700 · Cited by 5
“Other gastrointestinal tract diseases associated with malabsorption, such as inflammatory bowel disease or short bowel syndrome, have been associated with a higher prevalence of Bifidobacteria and Lactobacilli in several studies [41,42].”
BackgroundMesnage, R., Calatayud, M., Duysburgh, C., Marzorati, M., & Antoniou, M. N. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.16.472928 · Cited by 3
Molecular and cellular biology of bacterial lactate metabolism
McEwan, A. G., Hosmer, J., & Kappler, U. (2025) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2025.07.001 · Cited by 2
Faitová, T., Ilett, E. E., da Cunha‐Bang, C., Sengeløv, H., Brieghel, C., Gülay, A., Rafiq, S., Ravn, H. B., Zheng, C., Nielsen, R. V., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00944-25 · Cited by 3
Fan, Q., Tao, X., Huang, H., Jiang, S., Ren, H., Liu, Y., Yang, C., Wang, Y., Yan, K., Li, J., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157541 · Cited by 2
Yan, J., Qian, L., Chen, S., Karekad, M. M. A., Wu, X., Xu, M., & Xu, X. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1765550 · Cited by 5
Zhang, X., Hu, X., Li, J., Song, X., Wang, C., Chen, Y., Wu, S., Ma, L., Jiang, W., Cai, R., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1746351 · Cited by 3
Peng, T., Zhang, Z., Ding, N., & Zhang, J. (2026) · Neural Plasticity · doi:10.1155/np/6718671 · Cited by 2
Juyal, G., Sood, A., Midha, V., Singh, A., Singh, D., Mahajan, R., Verma, V., Bhatnagar, R., & Joshi, M. C. (2023) · Advanced Gut & Microbiome Research · doi:10.1155/2023/7333511 · Cited by 5
Хавкин, А. И., Михайлович, Н. К., Shrayner, E. V., Shaimardanova, D. R., Veremenko, A. S., Дмитриевна, Л. И., Platonova, P. Y., Novikova, M. F., & Валерьевна, Д. В. (2023) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-220-12-164-182 · Cited by 2
Activation of YAP/TAZ by gut microbiota via Wnt/β-catenin signaling in cancer development
Javanmard, S., & Ertürk, K. (2025) · Academia molecular biology and genomics. · doi:10.20935/acadmolbiogen7642 · Cited by 2
Yin, J. J., Hu, T., Zhang, L., Xu, L., Zhu, J., Ye, Y., & Pang, Z. (2025) · PeerJ · doi:10.7717/peerj.19959 · Cited by 3
“An increased proportion of Bifidobacterium was discovered to be higher in fecal and biopsy samples of active CD patients or UC patients ( Wang et al., 2014 ).”
Juyal, G., Sood, A., Midha, V., Singh, A., Singh, D., Mahajan, R., Verma, V., Bhatnagar, R., & Joshi, M. C. (2021) · medRxiv · doi:10.1101/2021.12.12.21267614 · Cited by 3
Romano, S., Wirbel, J., Ansorge, R., Schudoma, C., Ducarmon, Q. R., Narbad, A., & Zeller, G. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.05.569565 · Cited by 2
Tasoujlu, M., Sharifi, Y., Ghahremani, M., Alizadeh, K., Babaie, F., & Hosseiniazar, M. M. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10254-3 · Cited by 1
“Comparison of bacterial load in two groups revealed a higher load of Enterobacteriaceae from the stool samples of Fusobacterium spp. is a bacterium commonly found in the human oral cavity [ 35 ].”
InfluentialInflammatory Bowel Diseases and Gut Microbiota
Jana, B. K., Singh, M., Sarkar, T., Sadhu, P., Chetia, D., & Mazumder, B. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815324549125010005
Ni, N., Jiang, Z., Wang, Q., Ren, X., Tian, X., & Yu, L. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.108059 · Cited by 1
Zhang, H.-M., Zhang, Y., Luo, G.-J., Zhang, A.-X., Li, R.-C., Hai-bo, D., Dong, T.-Y., Yu, P.-C., An, Y., & Li, Y. (2025) · World Journal of Stem Cells · doi:10.4252/wjsc.v17.i12.112100 · Cited by 2
“Similar to previous studies[63,64], our study also showed that Lactobacillus populations decreased in the model group on day 25 but recovered by day 39 in the hUC-MSC groups (Figure 7C, Supplementary Figures 2A and 3).”
Zhou, Y., Sun, M., Zhang, Z., Wu, H. Y., & Zhao, D. (2026) · Frontiers in Veterinary Science · doi:10.3389/fvets.2026.1769005 · Cited by 1
“Compensatory increases in beneficial bacteria like Lactobacillus [crucial for gut barrier repair; (60, 61)] was observed during this phase, with its abundance significantly higher in under-change group than post-change group.”
Metabolism of β -mannans by representative, understudied Bacillota species from the human colon
Lo, G., Rosa, S. L. L., Westereng, B., Pope, P. B., Louis, P., Sabater, C., & Duncan, S. H. (2026) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiag063 · Cited by 1
“Ad-ditionally, Bifidobacterium and Lactobacillus spp. were reported to be increased in individuals with active inflammatory bowel disease while butyrate-producing Bacillota were decreased (Wang et al. 2014 ).”
Role of the Human Microbiome in Health and Disease in United Kingdom
Wesley, A. (2023) · International Journal of Natural Sciences · doi:10.47604/ijns.2177 · Cited by 1
“…into various research gap categories that is conceptual, contextual and methodological gaps Conceptual Research Gaps: While the studies mentioned (Wang, 2017) provide valuable insights into various aspects of the microbiome and its impact on health, there are several conceptual research gaps…”
BackgroundVeränderte intestinale bakterielle Zusammensetzung bei Patienten mit Histaminintoleranz
Schink, M., Konturek, P. C., Tietz, E., Dieterich, W., Neurath, M. F., & Zopf, Y. (2019) · Aktuelle Ernährungsmedizin · doi:10.1055/a-0901-2481 · Cited by 1
“Erhöhte Anteile an Proteobacteria wurden auch bereits schon in Patienten mit chronisch-entzündlichen Darmerkrankungen und Reizdarmsyndrom beschrieben [25, 29].”
BackgroundInfluentialPolysaccharides on the gut microbiome and epigenome
Duttaroy, A. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822405-2.00021-9 · Cited by 1
A Narrative Review of the Gut Microbiota and Its Association with Diseases
Nashin, D. (2022) · Science Insights · doi:10.15354/si.22.re016 · Cited by 1
“Although CD and UC patients are both high in lactobacilli and bifidobacteri, the Clostridium flexis group in these two diseases is dramatically reduced (27, 28), suggesting that probiotics should be administered cautiously in the acute phase of IBD patients.”
BackgroundThursby, E. (2016) · UEA Digital Repository (University of East Anglia) · Cited by 1
Diet‐Based Microbiome Modulation: You are What You Eat
Li, J., Qu, Z., Liu, F., Hao, J., Pan, Y., Guo, S., & Ho, C. L. (2022) · Wiley eBooks · doi:10.1002/9783527825462.ch1 · Cited by 1
Mikrobiom und Ernährung. Therapie der Zukunft für chronisch-entzündliche Darmerkrankungen?
Schreiber, S., Nikolaus, S., & Rosenstiel, P. C. (2014) · Der Internist
Effects of prebiotics on gut bacterial communities and healing of induced colitis in mice
Davis, K. E. (2016) · Aquila Digital Community (University of Southern Mississippi)
Shi, H., Sun, H., Zheng, R., Lu, S., Liu, F., Zhang, N., Xue, C., & Tang, Q. (2016) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2016.410003
“This work is licensed under the Creative Commons Attribution International License (CC BY 4.0). http://creativecommons.org/licenses/by/4.0/ Open Access”
MethodInfluentialFlies to Humans - Humans to Flies: A Virtuous Circle of Colorectal Cancer Prevention
Apidianakis, Y. (2017) · Archives of Clinical Gastroenterology · doi:10.17352/2455-2283.000038
Microbiota profiling in gastrointestinal health and disease
Tedjo (2018) · Research Publications (Maastricht University) · doi:10.26481/dis.20180301dt
Gut Microbiota as Signatures in Non-communicable Diseases and Mucosal Immunity
Behera, S. K., Praharaj, A. B., Chalikonda, G., Srivani, G., & Mahapatra, N. (2020) · Diagnostics and therapeutic advances in GI malignancies · doi:10.1007/978-981-15-2017-4_11 · Cited by 1
Sudhakar, P. (2020) · European Journal of Sustainable Development Research · doi:10.29333/ejosdr/7843
“* denote marketable services Protecting services ● Prevent landscape change ● Information on keystone species ● Imparting protection based on sense of place attributes ● Ritual regulations and cultural prohibitions References (Horiuchi et al., 2011) (Garibaldi and Turner, 2004; Wangpakapattanawong et al., 2010) (Cuerr…”
BackgroundInfluentialResearch Progress on the Relevance between Intestinal Flora and Colorectal Cancer
Hui, Y., Hou, J., Jia, Y., Dong, M., Feng, F., Jiang, J., & Yang, D. (2020) · Advanced Emergency Medicine · doi:10.18686/aem.v9i2.165
“Through high-throughput sequencing technology, the fecal samples and intestinal cavity microbes of colon cancer patients and normal people were analyzed and compared, and it was found that the number of digestive streptococcus in the excreta of colon cancer patients increased compared with that of healthy people[12-15…”
BackgroundIntestinal microbiota assembly and dynamics in health and disease
Galazzo, G. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20211105gg
Amaral, A. R. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.10.2020.tde-21012021-093129 · Cited by 1
Escherichia coli Strains in Patients with Inflammatory Bowel Diseases: A Review
Al-Amrah, H., Alotaibi, H., & Sadiq, N. (2022) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/2966
Spierings, J., van Rhijn-Brouwer, F. C. C.-C., & van Laar, J. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-79026-8_24
(2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811351-6.00026-7
Comparison of Sampling Methods in Assessing the Microbiomefrom Patients with Ulcerative ColitisPreprint
Kim, D., Jung, J.-Y., Oh, H.-S., Jee, S.-R., Park, S. J., Lee, S., Yoon, J.-S., Yu, S. J., Yoon, I.-C., & Lee, H. S. (2021) · Research Square · doi:10.21203/rs.3.rs-540741/v1
Interaction between Dietary Factors and Gut Microbiota in Ulcerative Colitis
Sung, M. (2022) · Journal of Digestive Cancer Research · doi:10.52927/jdcr.2022.10.1.31
Malek, A. E., & Okhuysen, P. C. (2022) · Springer eBooks · doi:10.1007/978-3-031-00241-0_8 · Cited by 1
Metabolomics and Its Role in Inflammatory Bowel Disease: What Do We Know?
Tsonev, N., Zvezdov, D., Gashkova, D., Andreeva, D., & Stefanova, M. (2022) · International Journal of Innovative Research in Medical Science · doi:10.23958/ijirms/vol07-i11/1555
Wang, W., Cheng, Z., Wang, X., Qin, A., Huang, K., Dai, Y., Meng, Q., & Zhang, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1883790/v2
Self-citationEnhancement of Probiotic Yogurts’ Characteristics using a 24-hour fermentation process
Ayoub, S., Alnaimi, N., Ibrahim, S., Manyama, J., Al-Marri, M., Naimi, A. J. A., Altamimi, A., Ansari, A. A., Esteban, C., Gaskell, C., et al. (2023) · Journal of Student Research · doi:10.47611/jsr.v11i3.1746
Metabolomics And Its Role in Inflammatory Bowel Disease-What Do We Know?
Tsonev, N. (2022) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2022.17.002356
da Rocha, I. M. G. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-23082023-154649 · Cited by 1
Toward paratuberculosis control in animals: current updates and future perspectives
El-Sayed, A., Kamel, M. S., & Zschöck, M. (2024) · Journal of the Hellenic Veterinary Medical Society · doi:10.12681/jhvms.27358
Identification of mucosal microbiome-host gene interactions in ulcerative colitis patientsPreprint
Kim, N., Gim, J., Lee, B. J., Choi, B. I., Yoon, H. S., Kim, W. S., Kim, S. H., Joo, M. K., & Park, J. (2024) · Research Square · doi:10.21203/rs.3.rs-3936546/v1
The gut microbiome in the onset and progression of Inflammatory Bowel Diseases
Klaassen, M. A. Y. (2024) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.909058157
Review on the Treatment of Dry Eye Based on Intestinal Axial Theory
王, 伟. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.14112859
Mendez, H., & Rijkers, G. T. (2025) · Exploration of Immunology · doi:10.37349/ei.2025.1003191 · Cited by 1
Detman, A., Schiro, G., Filip, R., Samborowska, E., Karczmarski, J., Jakubowska, K., Jarmakiewicz-Czaja, S., Williams, A., Hickman, N., Laubitz, D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.29.656803 · Cited by 1
“This dysregulation could also account for the observed higher prevalence of Bifidobacterium bifidum in the stools of CD patients compared to healthy individuals 63 .”
Lobzin, Y. V., Gorelov, A. V., Гриценко, В. А., Migacheva, N. B., Usenko, D. V., & Ермоленко, К. Д. (2025) · Allergology and Immunology in Pediatrics · doi:10.53529/2500-1175-2025-3-6-16
Selma-Royo, M., Calatayud Arroyo, M., García‐Mantrana, I., Parra-Llorca, A., Escuriet, R., Martínez‐Costa, C., & Collado, M. C. (2020) · Figshare · doi:10.6084/m9.figshare.13278689
Selma-Royo, M., Calatayud Arroyo, M., García‐Mantrana, I., Llorca, A. P., Escuriet, R., Martínez‐Costa, C., & Collado, M. C. (2020) · Figshare · doi:10.6084/m9.figshare.13278680
Ambrożkiewicz, F., Karczmarski, J., Kulecka, M., Paziewska, A., Niemira, M., Zeber-Lubecka, N., Zagórowicz, E., Kretowski, A., & Ostrowski, J. (2021) · Figshare · doi:10.6084/m9.figshare.14125111
Armstrong, H., Rahbari, M., Park, H., Sharon, D. M., Thiesen, A., Hotte, N., Sun, N., Syed, H., Abofayed, H., Wang, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22621349
Self-citationSelma-Royo, M., Calatayud Arroyo, M., García‐Mantrana, I., Parra-Llorca, A., Escuriet, R., Martínez‐Costa, C., & Collado, M. C. (2020) · Figshare · doi:10.6084/m9.figshare.13278671
Selma-Royo, M., Calatayud Arroyo, M., García‐Mantrana, I., Llorca, A. P., Escuriet, R., Martínez‐Costa, C., & Collado, M. C. (2020) · Figshare · doi:10.6084/m9.figshare.13278677
Selma-Royo, M., Calatayud Arroyo, M., García‐Mantrana, I., Llorca, A. P., Escuriet, R., Martínez‐Costa, C., & Collado, M. C. (2020) · Figshare · doi:10.6084/m9.figshare.13278665
Armstrong, H., Rahbari, M., Park, H., Sharon, D. M., Thiesen, A., Hotte, N., Sun, N., Syed, H., Abofayed, H., Wang, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22621346
Self-citationSadeghi, O., Milajerdi, A., Siadat, S. D., Keshavarz, S. A., Sima, A. R., Vahedi, H., Adibi, P., & Esmaillzadeh, A. (2020) · Figshare · doi:10.6084/m9.figshare.12552539
Selma-Royo, M., Calatayud Arroyo, M., García‐Mantrana, I., Llorca, A. P., Escuriet, R., Martínez‐Costa, C., & Collado, M. C. (2020) · Figshare · doi:10.6084/m9.figshare.13278695
Selma-Royo, M., Calatayud Arroyo, M., García‐Mantrana, I., Parra-Llorca, A., Escuriet, R., Martínez‐Costa, C., & Collado, M. C. (2020) · Figshare · doi:10.6084/m9.figshare.13278701
Bosselaar, S., Dhelin, L., Dautel, E., Titécat, M., Duthoy, S., Stelmaszczyk, M., Delory, N., Violante, M. D. S., Machuron, F., Ait-Abderrahim, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26741048
Mohamed, S. S., Abdeltawab, N. F., Wadie, W., Ahmed, L. A., Ammar, R. M., Rabini, S., Abdel-Aziz, H., & Khayyal, M. T. (2021) · Figshare · doi:10.6084/m9.figshare.14752070
Armstrong, H., Rahbari, M., Park, H., Sharon, D. M., Thiesen, A., Hotte, N., Sun, N., Syed, H., Abofayed, H., Wang, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22621340
Self-citationSelma-Royo, M., Calatayud Arroyo, M., García‐Mantrana, I., Parra-Llorca, A., Escuriet, R., Martínez‐Costa, C., & Collado, M. C. (2020) · Figshare · doi:10.6084/m9.figshare.13278686
Bosselaar, S., Dhelin, L., Dautel, E., Titécat, M., Duthoy, S., Stelmaszczyk, M., Delory, N., Violante, M. D. S., Machuron, F., Ait-Abderrahim, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26741045
Wang, W., Cheng, Z., Wang, X., An, Q., Huang, K., Dai, Y., Meng, Q., & Zhang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24472477
Self-citationSelma-Royo, M., Calatayud Arroyo, M., García‐Mantrana, I., Parra-Llorca, A., Escuriet, R., Martínez‐Costa, C., & Collado, M. C. (2020) · Figshare · doi:10.6084/m9.figshare.13278683
Selma-Royo, M., Calatayud Arroyo, M., García‐Mantrana, I., Llorca, A. P., Escuriet, R., Martínez‐Costa, C., & Collado, M. C. (2020) · Figshare · doi:10.6084/m9.figshare.13278698
Armstrong, H., Rahbari, M., Park, H., Sharon, D. M., Thiesen, A., Hotte, N., Sun, N., Syed, H., Abofayed, H., Wang, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22621343
Self-citationSelma-Royo, M., Calatayud Arroyo, M., García‐Mantrana, I., Llorca, A. P., Escuriet, R., Martínez‐Costa, C., & Collado, M. C. (2020) · Figshare · doi:10.6084/m9.figshare.13278692
Armstrong, H., Rahbari, M., Park, H., Sharon, D. M., Thiesen, A., Hotte, N., Sun, N., Syed, H., Abofayed, H., Wang, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22621352
Self-citationInflammation is the Driver of Butyrate-Producing Bacteria Change in Interleukin10 Knockout MicePreprint
Kim, J. Y., Park, B., Riffey, O. F., Bunch, M. L., Johnson, J. G., Burcham, Z. M., & Donohoe, D. R. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.15.699743
Sikdar, S., Dutta, P., Mitra, D., & Samanta, A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.03.703214
“Over the years, SCFAs have been studied not only on the gut inflammation and barrier disruption [17],[18],[19],[20] but also their levels are directly associated with hyperglycaemia [21],[22] , colorectal cancer [23] , obesity [24] , and autoimmune disorders [25] .”
Zhang, Z., Hu, X., & Ma, Y. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1765748 · Cited by 2
Microbiome-based biomarkers for inflammatory bowel disease diagnosis and prognosis
Salar, M. Z., Ghafoor, N., Ghafoor, A., & Baig, A. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40483-2.00010-8
Study of human perinatal B cells in the context of intestinal microbial colonization
Gu, Q. (2024) · theses.fr (ABES) · doi:10.70675/fdf94bf2z3bd1z42bezb8f0z3bb3a42a8771
Composition and diversity of gut microbiota in non-erosive reflux disease
Wei, X., Wang, G., Wei, Y., Zhang, T., Lu, M., Xu, L., Zhang, B., & Tang, X. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1795756
Self-citationLi, Z., Zhang, Q., Yang, J., Lei, R., & Lu, W. (2026) · Scientific Reports · doi:10.1038/s41598-026-52084-8
Gut microbial metabolites as key mediators in inflammatory bowel disease
Sall, T. S., Litvinova, E., Arzhanova, E. L., Sitkin, S. I., & Vakhitov, T. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.121041
Metadata
- Authors
- Wang, W., Chen, L., Zhou, R., Wang, X., Song, L., Huang, S., Wang, G., & Xia, B.
- Affiliations
- Zhongnan Hospital of Wuhan University (CN)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2014-02
- Volume
- 52
- Issue
- 2
- Pages
- 398-406
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC3911339
- OpenAlex
- W2097788076
- Cited by
- 509
- References
- 48
- Citations by year
- 2026: 26 · 2025: 46 · 2024: 47 · 2023: 56 · 2022: 74 · 2021: 56 · 2020: 53 · 2019: 39 · 2018: 29 · 2017: 24 · 2016: 28 · 2015: 12 · 2014: 19
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- inflammatory bowel disease, Crohn's disease, ulcerative colitis, gut dysbiosis, Bifidobacterium, Lactobacillus, Faecalibacterium prausnitzii, butyrate-producing bacteria, mucosa-associated bacteria, fecal bacteria, probiotics, 16S rRNA gene
- MeSH terms
- Adolescent, Adult, Bifidobacterium, Biopsy, Butyrates, Feces, Female, Humans, Intestinal Mucosa, Lactobacillus, Male, Middle Aged, RNA, Bacterial, RNA, Ribosomal, 16S, Inflammatory Bowel Diseases, Gastrointestinal Tract, Young Adult, Biota, Bacterial Load, Real-Time Polymerase Chain Reaction, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.